StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Here is a head-scratcher for IR to answer.

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Dec 29, 2020 9:56pm

165 Views

Post# 32194716

RE:RE:RE:Here is a head-scratcher for IR to answer.

https://www.technologynetworks.com/genomics/news/amp/genenews-announces-us-issuance-of-core-sentinel-principle-patent-195552

https://www.prnewswire.com/news-releases/genenews-announces-issuance-of-second-foundational-us-patent-for-core-sentinel-principler-technology-84460647.html

https://www.cbinsights.com/investor/genenews-patents

Nailbiter1 wrote:

Melray wrote:
WTF!

Sent an email to IR.
A few years ago I showed concerns about Prof Liew's company BGS in Malaysia.
James replied "no worries, we own the IP on Sentinel"
This company bought out BGS and have incorporated in the US.
I'll get to the bottom of it.